Amethyst

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amethyst

Property Description
Active ingredient Ethinyl Estradiol, Levonorgestrel
Form Oral tablet
Pharmacological class Combined Hormonal Contraceptive (CHC)
Common use Pregnancy prevention (Contraception)
Origin Synthetic (derived from chemical synthesis)

What Type of Medication is Amethyst?

Amethyst is a prescription-only oral contraceptive in tablet form, formally classified as a Combined Hormonal Contraceptive (CHC). This medication belongs to the systemic class of contraceptives, containing two chemically distinct, synthetic hormones. It is specifically intended for use by females of reproductive potential to prevent pregnancy.

The drug's core activity is established by its dual composition, featuring the synthetic estrogen Ethinyl Estradiol and the synthetic progestin Levonorgestrel. This combination places it among the forms of hormonal birth control with a primary mechanism of inhibiting ovulation.

The Composition and Unique Dosing Format

The product’s composition utilizes the two active ingredients, Ethinyl Estradiol and Levonorgestrel, which are delivered together as a combination product in each pill. Both components are manufactured through chemical synthesis, classifying them as non-naturally derived agents.

Amethyst’s most distinguishing feature is its continuous-dosing cycle, a regimen not shared by the majority of conventional 28-day contraceptive packs. This formulation provides continuous hormonal exposure because every tablet in the pack is active, designed to eliminate the standard hormone-free interval. This continuous supply of hormones is utilized to maintain constant suppression of the fertility cycle.

Amethyst’s General Purpose

The general, single purpose of Amethyst is to provide reliable contraception to prevent pregnancy. This objective is based on the use of synthetic hormones to block the signals that lead to the release of an egg from the ovary, a process known as inhibition of ovulation.

Furthermore, the continuous hormonal exposure also induces key, secondary changes, including the thickening of the cervical mucus and alterations to the uterine lining. These combined effects ensure that the medication provides a multi-layered and continuous mechanism for pregnancy prevention.

Regulatory References

  1. FDA DailyMed: Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets)
  2. NIH: Oral Contraceptive Pills - Mechanism of Action

What side effects are possible with Amethyst?

The official safety profile for this Combined Hormonal Contraceptive (CHC) is structured around frequency-classified adverse reactions and serious, documented risks.

Adverse Reaction Classifications

Side effects are categorized by the physiological system they affect (System-Organ Class) and their official frequency. Very common reactions typically include headache and irregular uterine bleeding (spotting or breakthrough bleeding), particularly during the initial months of use. Common reactions often involve gastrointestinal issues, such as nausea and abdominal pain, along with breast tenderness and weight gain. Uncommon and Rare events are also defined in regulatory labeling, including migraine and the development of specific vascular disorders.

Serious Safety Considerations

The most significant and officially documented serious adverse reactions are related to thromboembolic events, specifically Venous Thromboembolism (VTE) (including deep vein thrombosis and pulmonary embolism) and Arterial Thromboembolism (ATE) (including stroke and myocardial infarction). The regulatory documents confirm that the risk of VTE is highest during the first year of therapy. Other rare but serious documented risks include Hepatic Tumors (benign or malignant) and new-onset or worsening Hypertension.

Population-Specific Constraints

The regulatory label establishes strict contraindications based on risk factors. The medication is officially constrained from use in women over 35 years of age who smoke, due to a significantly increased risk of serious cardiovascular events. Official constraints also apply to individuals with a history of VTE/ATE, severe hepatic disease, uncontrolled hypertension, or a history of migraine with aura.

The overall safety profile is therefore defined by balancing common hormonal adjustment effects with the clear communication of rare but critical vascular risks and adherence to stringent, documented population-specific limitations.

Overdose and Emergency Response

Overdose and when to seek help

This information details the official guidance and documented clinical manifestations related to an acute overdose of the combined hormonal contraceptive, Amethyst (Ethinyl Estradiol and Levonorgestrel), as defined by government regulatory authorities.

Overdose Manifestations Official Regulatory Status
Documented Signs Nausea, vomiting, and expected withdrawal bleeding in females.
Antidote Availability No specific antidote is known to counteract the effects.

Severity and Emergency Response

Acute ingestion of large doses of this oral contraceptive is generally classified as not likely to be life-threatening in official prescribing information. Regulatory documentation explicitly states that serious ill effects have not been reported following acute ingestion of large doses of oral contraceptives, including observations specific to young children who may accidentally ingest the tablets.

In the event of a suspected overdose, the prescribed clinical management is restricted to symptomatic and supportive treatment. Users are officially directed to seek immediate medical attention for thorough evaluation, observation, and clinical management of any persistent or concerning signs. Contacting a poison control center or emergency medical services is the required initial step in the regulatory-mandated emergency response for overdose.

Therapeutic Uses of Amethyst

The primary use of Amethyst is for sustained contraceptive protection, providing sustained pregnancy prevention for patients in the reproductive years. This application assists with maintaining functional stability and offers support for contraceptive stability, contributing to easing the impact of reproductive risk on routine activities.

This therapeutic support is also applied across domains where additional symptomatic assistance is needed. It is commonly used to help manage severe Dysmenorrhea (painful cramping), Menorrhagia (heavy blood loss), and Acne vulgaris that is linked to hormonal activity. The application is relevant for non-cyclic menstrual control, which may lead to Amenorrhea (absence of scheduled bleeding).

“This approach provides support that helps ease the patient's discomfort by assisting with managing symptoms related to systemic imbalance.”

In these contexts, the medication helps address groups of symptoms that may become intense or disruptive. The overall benefit is offering symptomatic relief that helps patients cope more steadily with difficult episodes and contributes to easing the overall symptom load.


Quick Fact: Symptomatic Support for Menstrual Discomfort The dosing format is commonly used when symptoms intensify, providing support that contributes to easing the overall symptom load associated with painful cramping and excessive bleeding.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Amethyst

Amethyst (levonorgestrel and ethinyl estradiol) is an estrogen- and progestin-containing medicine. Its use is limited to females who do not have specific health conditions that significantly increase the risk of serious complications.

Contraindicated Populations

Use is contraindicated (prohibited) for females with:

  • Cardiovascular and Thrombotic Risk: A high risk of arterial or venous thrombotic diseases, including a history of deep vein thrombosis, pulmonary embolism, stroke, coronary artery disease, or inherited/acquired blood clotting disorders.
  • Smoking and Age: Females over age 35 who smoke.
  • Cancer: Current or history of breast cancer or other estrogen- or progestin-sensitive cancers.
  • Liver Disease: Liver tumors (benign or malignant) or active liver disease.
  • Pregnancy: The medicine is contraindicated during pregnancy.
  • Undiagnosed Bleeding: Undiagnosed abnormal genital bleeding.
  • Drug Interactions: Concomitant use with specific Hepatitis C drug combinations (containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir).

Other Restrictions and Considerations

  • Age: Women over 40 who are healthy and non-smoking may use the medicine, but should be on the lowest effective dose.
  • Lactation: Use is generally not recommended in nursing mothers as it may decrease milk production.
  • Surgery: The medicine should be stopped at least four weeks before and through two weeks after major surgery due to the elevated risk of blood clots.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information identifies specific drug classes and substances that can interact with Amethyst, leading to altered plasma concentrations of its hormonal components or increased risks of adverse events.

Specific Interacting Substances and Required Restrictions

Interaction Type Examples of Interacting Products/Substances
Increased Cardiovascular Risk Cigarette smoking (especially in females over 35 years of age)
Enzyme Inducers/Inhibitors Certain anticonvulsants, anti-tuberculosis drugs (e.g., rifampin), anti-HIV protease inhibitors, St. John's wort, grapefruit juice
Compounding Effects Products affecting the metabolism of estrogen/progestin, thyroid hormones, certain corticosteroids

Combined hormonal contraceptives are officially contraindicated in females over 35 years of age who smoke cigarettes due to a major increase in the risk of serious cardiovascular events. Concomitant use with the combination drug regimen ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, is also strictly contraindicated. Discontinuation of Amethyst is required prior to starting this anti-hepatitis C regimen, with restarting possible approximately two weeks after completion.

Interactions involving drugs like certain anticonvulsants or antibiotics may result in lower plasma levels of the contraceptive hormones due to the induction of hepatic enzymes, potentially compromising the effectiveness of Amethyst. Conversely, concurrent use with certain products, such as grapefruit juice or certain anti-HIV drugs, may increase the plasma concentration of the hormones. Consult the official regulatory labeling for a comprehensive list of all interacting products, including specific anti-HIV medications and anti-seizure drugs, and always follow the documented restrictions and requirements.

Mechanism of Action

How Amethyst Works

Hormonal Suppression of the Reproductive Axis

The drug's active synthetic components function as molecular agonists, primarily targeting the Estrogen ( ER) and Progesterone ( PR) receptors in the brain's regulatory centers, specifically the hypothalamus and pituitary gland. This interaction creates continuous negative feedback, which inhibits the release of hormones necessary for follicle maturation and prevents the Luteinizing Hormone ( LH) surge that triggers egg release. The resulting physiological consequence of this systemic modulation is anovulation (the inhibition of egg release).


Creation of Peripheral Barriers

The synthetic progestin component exerts a secondary, localized influence by acting on PR in the lower reproductive tract. This action modifies the texture of the cervical mucus, significantly increasing its viscosity and reducing its permeability. Concurrently, it reduces the receptivity of the endometrial lining by causing it to become less proliferative. These localized actions function in conjunction with the central hormonal suppression mechanism.

Dosage and Administration Information

The administration of Amethyst is defined by a rigorous continuous daily oral regimen, a pattern distinct from conventional contraceptive cycles that include a hormone-free interval. This medication is available as an oral tablet, and the dose is one tablet containing 90 mu g of Levonorgestrel and 20 mu g of Ethinyl Estradiol. The primary route of administration is oral, with the tablet swallowed whole.


Standardized Dosing and Frequency

The standard dose requires taking one active tablet daily, which must be taken at the same time each day to ensure consistent hormonal suppression. This continuous use pattern spans a 28-day cycle, with the next cycle commencing immediately without any break. This regimen supports a long-term treatment course intended for females of reproductive potential.

Administration Procedures and Conditions

Therapy can be initiated using either a Day 1 start or a Sunday start procedure. Taking the dose with or after a meal, or at bedtime, may be utilized to aid patient tolerability, although the dose is not strictly dependent on food intake.

Established procedures exist for managing a missed dose. If a single tablet is missed, it is typically taken as soon as remembered, with the next tablet taken at the usual time. Missing two or more tablets involves following specific instructions that outline a course of action. Special procedural conditions also apply when initiating the medication postpartum, where the course begins no earlier than 28 days postpartum in the nonlactating population.

Recent Clinical Evidence

Research Overview

The research base for this medication draws from large-scale clinical trials and long-running observational studies involving females of reproductive age. Efficacy for contraceptive use is measured by the Pearl Index, a calculation that tracks the number of pregnancies observed over one year. Findings show the importance of adherence, and research cannot predict whether an individual will respond similarly to the group patterns observed in these studies.

Symptomatic Relief and Specific Indications

The evidence base for symptomatic uses includes randomized, controlled trials. Research has explored the use of the medication for painful periods (Dysmenorrhea) and heavy menstrual bleeding (Menorrhagia). For painful periods, trials measured patient-reported scores related to physical discomfort. For heavy bleeding, studies quantified changes in menstrual blood loss (MBL) using standardized methods. Research describes measured changes in MBL and symptom evolution over six to twelve cycles. Evidence is limited regarding direct comparisons of continuous dosing versus traditional cyclic dosing for symptomatic management.

Research Gaps and Uncertainty

Trials for hormonal acne tracked changes in skin lesions, indicating that maximum observed changes often extended over six months or more. While long-term studies monitored physiological markers and general durability of outcomes for hormonal contraceptives, the certainty regarding sustained symptomatic response for this specific continuous regimen remains to be fully established. Furthermore, data for certain subgroups, such as adolescents or women with specific body mass indices, are insufficient for definitive conclusions.

Key Studies & References

  1. Official FDA Labeling for Ethinyl Estradiol and Levonorgestrel Extended-Cycle Tablets
  2. Combined Hormonal Contraceptives: Efficacy, Safety, and Mechanism of Action (NIH/MedlinePlus)

Frequently Asked Questions (FAQ)

Common questions about Amethyst (FAQ)


Q: How long does it typically take to notice the effect of Amethyst?

According to the official product information, the contraceptive effect is generally established after taking the active tablets for seven consecutive days. However, if the medication is started within the first five days of a menstrual period, official guidance indicates that protection may be considered immediate.


Q: What happens if a dose of Amethyst is missed?

Regulatory documents provide guidance for managing missed tablets. If one active tablet is missed, official guidance recommends it be taken as soon as it is remembered. The next tablet should then be taken at the usual scheduled time.


Q: Does Amethyst interact with common over-the-counter pain relievers?

Official information states that certain common over-the-counter pain relievers, such as acetaminophen or acetylsalicylic acid (aspirin), may decrease the rate at which the body processes the estrogen component in the medication. This interaction is described in the drug label.


Q: Is it necessary to avoid certain foods or drinks while using Amethyst?

The regulatory label lists an interaction where consuming grapefruit juice may lead to higher blood levels of the levonorgestrel component of the medicine. Official drug interaction warnings do not cite other foods or drinks that require avoidance.


Q: Can Amethyst cause weight change?

According to the official prescribing information, weight changes—which may include either an increase or a decrease—and weight gain are listed among the common side effects that can occur with the use of this medication.


Q: Is it possible to be allergic to Amethyst?

Yes, official safety information states that use is contraindicated (prohibited) for anyone with a known hypersensitivity (an allergic reaction) to the drug or any of its inactive ingredients.


Q: Does Amethyst affect sleep patterns?

Sleep problems have been documented in association with symptoms of depression, which is listed as a possible adverse reaction related to combined hormonal contraceptives. Users should note this potential relationship described in official documents.


Q: Does alcohol consumption change the effects of Amethyst?

Official sources indicate that there is no established direct drug-alcohol interaction that changes the medication's chemical effectiveness. The primary concern relates to heavy consumption potentially leading to vomiting or forgetting to take a scheduled dose.


Q: Does Amethyst interact with birth control pills?

Amethyst is classified as a Combined Hormonal Contraceptive (CHC) itself. It is not intended to be used simultaneously with other hormonal methods of birth control.


Q: Is Amethyst meant to cure a condition or manage its symptoms?

The drug’s main purpose is the prevention of pregnancy (contraception). Official research has also explored its use to manage symptoms associated with certain menstrual conditions, such as painful or heavy bleeding, and to treat acne.


Q: Is Amethyst the same type of medicine as [similar drug name]?

Amethyst is classified as a Combined Hormonal Contraceptive (CHC) containing both estrogen and progestin. Its distinct feature, according to the official label, is its continuous-dosing regimen without the standard hormone-free week, which differs from many traditional cyclic pills.


Q: Can Amethyst be taken indefinitely, or is it for short-term use?

Amethyst is described in official documents as a continuous low-dose oral contraceptive designed for a long-term treatment course intended for pregnancy prevention. Official labeling does not define a maximum duration of use, but the treatment course is intended to be long-term.


Q: What is the usual recommended timeframe for using Amethyst?

The medication is intended for continuous daily use as a long-term method for pregnancy prevention. The typical timeframe extends for as long as contraception is desired and the medication is medically appropriate.


Q: Is Amethyst considered a controlled substance?

Amethyst is classified as a prescription drug but is not designated as a controlled substance by the US Drug Enforcement Administration (DEA) or equivalent international agencies.


Q: What is the difference between Amethyst and a placebo in clinical trials?

In clinical trials, Amethyst contains the active hormones (levonorgestrel and ethinyl estradiol). A placebo is an inactive substance used for comparison that contains no active medicine.


Q: Are there any known long-term effects of Amethyst use?

Long-term use of combined hormonal contraceptives is associated with documented risks, including those related to blood clots and an increased incidence of breast cancer, as described in official regulatory summaries.


Q: Can Amethyst be split or crushed?

Official instructions state that the tablet should be swallowed whole for oral administration. Regulatory information does not typically recommend or provide guidance for altering the form of the tablet by splitting or crushing.


Q: What is the reason Amethyst might stop working for someone?

The effectiveness of the medication may be reduced by factors such as missing doses, episodes of vomiting or severe diarrhea, and the concurrent use of certain other medications, such as enzyme-inducing drugs.


Q: Is Amethyst absorbed better on an empty stomach?

Official regulatory information states that the effect of food on the absorption of the medicine's active ingredients has not been specifically evaluated. The dose may be taken with or after a meal for better tolerability.


Q: Are there different strengths or formulations of Amethyst available?

Amethyst is available in a single continuous-dosing tablet strength. This tablet contains a fixed amount of Levonorgestrel and Ethinyl Estradiol.


Q: What regulatory bodies have approved Amethyst?

This medication has been approved by major regulatory bodies for the prevention of pregnancy. This includes the U.S. Food and Drug Administration (FDA).


Q: Is there a generic version of Amethyst available?

Yes, a lower-cost generic version of the medication containing levonorgestrel and ethinyl estradiol is approved and available for use.


Q: Is it normal to feel slightly dizzy after starting Amethyst?

Dizziness is not listed as a common or very common side effect in official documents. It is documented as a symptom that may accompany rare, more serious events, such as severely high blood pressure or stroke.


Q: Can Amethyst cause changes in mood or behavior?

Official adverse reaction information lists changes in mood and feelings of depression as possible side effects associated with the use of the medicine.


Q: Why is Amethyst sometimes prescribed for conditions other than its main use?

While primarily indicated for contraception, official research has explored the use of the medication for the management of symptoms associated with painful periods (Dysmenorrhea), heavy menstrual bleeding (Menorrhagia), and acne.


Q: How long does Amethyst stay in the body after stopping use?

The two active components are eliminated from the body at different rates. The half-life of Levonorgestrel (progestin) is approximately 30 hours, and the half-life of Ethinyl Estradiol (estrogen) is approximately 12 hours with chronic use.


Q: Are there any mandatory monitoring or blood tests required while on Amethyst?

Regulatory guidance states that individuals taking the medicine are typically required to have their blood pressure checked regularly. Blood work and other lab tests may also be required, as well as regular gynecology and breast check-ups.


Q: If I have allergies, is Amethyst still safe to use?

Use is officially contraindicated (prohibited) in patients with a known hypersensitivity (allergic reaction) to the drug or any of its ingredients. The regulatory label specifies that use is prohibited in this population.

How should Amethyst be stored and disposed of?

How to Store and Dispose of Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets)

Storage Requirements

Amethyst must be stored at Controlled Room Temperature, which is defined by regulatory bodies as 20^circC to 25^circC (68^circF to 77^circF). Storage must be maintained within the original container and blister pack to ensure product integrity and stability. The medicine must be kept out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Official regulatory guidelines for unused or expired Amethyst recommend utilizing a drug take-back program or mail-back envelope as the preferred disposal method. If no take-back option is available, the product may be discarded in the household trash by mixing the uncrushed tablets with an unappealing substance, sealing the mixture in a separate container, and removing all personal information from the prescription label before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amethyst found in:

A-Z Index: